Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04614935 · ClinicalTrials.gov registry record · NA
Adherence and Outcomes in Functional Constipation With a Constipation Action Plan
A NA study of Pediatric ALL and Adherence, Medication, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT04614935: Completed NA study of Pediatric ALL and Adherence, Medication, sponsored by University of Alabama at Birmingham.
NCT04614935 is a NA study of Pediatric ALL and Adherence, Medication that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 38 participants, below the 1,646-participant average among 21 other Pediatric ALL trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04614935, a NA study of Pediatric ALL and Adherence, Medication, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
We will be assessing for improvement in reported symptoms as well as reported quality of life in pediatric patients with functional constipation using a constipation action plan and an adherence log.
Primary Outcome
Calendar where families place a colored sticker (green, yellow, or red, depending on how symptoms correlate to the constipation action plan), measured as a ratio of total number of days logged/total number of days possible to log. Adherence log will be reviewed at each follow appointment (2 month and 4 month).
Conditions Studied
Interventions
- BEHAVIORAL Action Plan
Study Locations (1)
Alabama
- UAB/COA - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
What the finished NCT04614935 record still lists
NCT04614935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,646-participant average among 21 other Pediatric ALL trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Action Plan is the first listed.
NCT04614935 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04614935 about?
NCT04614935 is a clinical study titled "Adherence and Outcomes in Functional Constipation With a Constipation Action Plan". We will be assessing for improvement in reported symptoms as well as reported quality of life in pediatric patients with functional constipation using a constipation action plan and an adherence log.
What is the current status of trial NCT04614935?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2020-11-01. Estimated completion is 2022-03-01.
What conditions does trial NCT04614935 study?
This clinical trial studies the following conditions: Pediatric ALL, Adherence, Medication, Functional Constipation, Survey, Family Life.
What interventions are being tested in trial NCT04614935?
The interventions under investigation include: Action Plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT04614935?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04614935 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04614935's enrollment target sits among peer trials
38 16th of 21 higher than 6 of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI